ProfileGDS4095 / 201903_at
TitleTamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
OrganismHomo sapiens


SRC1 knockdown control tamoxifen untreated tamoxifen untreated GSM709767 GSM709769 GSM709765 GSM709771 GSM709772 GSM709775 GSM709764 GSM709766 GSM709768 GSM709777 GSM709770 GSM709773 GSM709774 GSM709776 75% 75% 76% 76% 77% 76% 76% 76% 77% 75% 77% 76% 75% 77% sort by genotype/variation sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM709767LY2 SRC1-siRNA tamoxifen treated rep17.7873475
GSM709769LY2 SRC1-siRNA tamoxifen treated rep37.8646875
GSM709765LY2 SRC1-siRNA untreated rep37.9485676
GSM709771LY2 SRC1-siRNA untreated rep18.0297576
GSM709772LY2 SRC1-siRNA untreated rep28.1531777
GSM709775LY2 SRC1-siRNA untreated rep48.0548776
GSM709764LY2 control-siRNA tamoxifen treated rep28.0787476
GSM709766LY2 control-siRNA tamoxifen treated rep37.9949376
GSM709768LY2 control-siRNA tamoxifen treated rep18.1762877
GSM709777LY2 control-siRNA tamoxifen treated rep47.8964975
GSM709770LY2 control-siRNA untreated rep38.2408577
GSM709773LY2 control-siRNA untreated rep17.9996376
GSM709774LY2 control-siRNA untreated rep27.862975
GSM709776LY2 control-siRNA untreated rep48.1766577